Plain-English translation of NCT07249918 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This pilot study is testing whether Re-Timer light-therapy glasses—eyewear that emits a specific wavelength of green light—can help reduce behavioral and sleep problems in people with Alzheimer's disease or mild cognitive impairment. The study also measures whether this treatment eases caregiver stress. Researchers will track changes using wearable activity monitors and caregiver assessments.
Many people with dementia experience difficult behavioral symptoms like agitation, depression, and sleep problems. Most current treatments rely on medications that may have serious side effects. This study explores whether a non-drug approach using light therapy could safely improve quality of life for both patients and the people who care for them.
You likely qualify if…
You likely don't qualify if…
You would wear the light-therapy glasses and a research activity monitor (a small wristband that tracks your movement and sleep). You and your caregiver would complete brief assessments at study visits to track changes in behavioral symptoms, sleep quality, and caregiver stress. The study is designed as a small pilot to see if this approach is acceptable and feasible in rural Taiwan, with about 20 participants total.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Taiwan